Moreld asked a very relevant question: Here's a question for all. Dr Leigh Farrell was appointed Vice President, Business Development on 24 April 2006. What deals has Dr Farrell done in the last 4.8 years?
RSV deal was done before his time, IIRC it was 2005, and I can't recall any deals done since. Certainly none since I became a shareholder in 2008.
Dr Leigh Farrell received an annual remuneration of $354,943 (for 2009), Shareholders are entitled to know what business has Dr Farrell developed?
We also have Steve Ruston appointed Managing Director Biota Europe on 12/11/09 with a $233,006 remuneration package for less than 8 months. What has he done in regard to GSK non marketing performance?
Perhaps someone should email PC and asked him what value have these people contributed.
BTA Price at posting:
$1.44 Sentiment: LT Buy Disclosure: Held
